SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update

ISSN: 2211-3533 (Online)
ISSN: 2211-3525 (Print)

Volume 15, 2 Issues, 2017

Download PDF Flyer

Anti-Infective Agents

Formerly: Anti-Infective Agents in Medicinal Chemistry

This journal supports open access

Aims & ScopeAbstracted/Indexed in

Submit Abstracts Online Submit Manuscripts Online

View Full Editorial Board

Subscribe Purchase Articles Order Reprints

SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update

Anti-Infective Agents, 11(1): 76-90.

Author(s): Irene Briguglio, Sandra Piras, Paola Corona, Maria A. Pirisi, Daniela Jabes and Antonio Carta.

Affiliation: Department of Chemistry and Pharmacy, University of Sassari, Via Muroni 23/a, 07100 Sassari, Italy.


Fluoroquinolones (FQ) are an important family of synthetic antimicrobial agents being clinically used over the past thirty years. Currently some FQ are under investigation for the treatment of multidrug-resistant tuberculosis (MDRTB), defined as resistance to at least isoniazid and rifampicin, and are under investigation as first-line drugs. Their main biological target in Mycobacterium tuberculosis is the DNA gyrase, a topoisomerase II encoded by gyrA and gyrB that is essential to maintain the DNA supercoil. It has been demonstrated that mutations in short regions of DNA gyrase are associated with quinolone resistance or hypersusceptibility and take place in several MDR clinical isolates of M. tuberculosis. In this article we update§ our previous review (Carta et al. Anti-infective agents, 2008, 7, 134-147) about the anti mycobacterial properties, mode of action and structure activity relationship (SAR) studies of the known quinolone derivatives. Furthermore, we update the synthesis and activity of 3,9-disubstituted-6-oxo-6,9-dihydro-3H-[1,2,3]-triazolo[4,5-h,g]quinolonecarboxylic acids and their esters as a new class of potent and selective anti-mycobacterial agents, coupled with absence of cytotoxicity. Furthermore, particularly interesting is their activity against MDR M. tuberculosis.


Anti-mycobacterial activity, DNA gyrase inhibitors, MDR-TB, quinolones, SAR analysis, triazoloquinolones antitubercular activity.

Download Free Order Reprints Order Eprints Rights and Permissions

Article Details

Volume: 11
Issue Number: 1
First Page: 76
Last Page: 90
Page Count: 15
DOI: 10.2174/22113626130109
Global Biotechnology Congress 2017Drug Discovery and Therapy World Congress 2017

Related Journals

Related eBooks

Webmaster Contact: Copyright © 2017 Bentham Science